Figure 13From: Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responsesAverage spot-forming cell counts (as determined by ELISpot assay specific for human IFN-γ, per million cells with baseline IFN-γ production in unstimulated cells subtracted) of the sixteen donors against the sixteen different synthetic influenza peptides and the included controls. The peptide that resulted in the highest SFC value is bolded for each donor, and higher SFC values are highlighted (light grey if between 20 and 99 and dark grey if above 100).Back to article page